Apellis shareholders re-elect Dunlop and Machiels as directors, ratify auditor and approve say-on-pay

Apellis Pharmaceuticals, Inc.

A. Sinclair Dunlop re-elected with 67,011,560 for vs 19,188,626 against, 8,818,334 broker non-votes.
Alec Machiels re-elected with 63,755,893 for vs 22,444,293 against, 8,818,334 broker non-votes.
Ratification of Deloitte & Touche as auditor for FY2022: 75,696,485 for, 19,169,304 against.
Advisory vote on executive compensation approved: 84,569,740 for, 1,617,364 against, 13,081 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.